Ubs Group Ag Iterum Therapeutics PLC Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.19 - $0.36 $5,601 - $10,614	-29,484 Reduced 100.0%	1 $0
Q1 2022 May 16, 2022	SELL	$0.31 - $0.45 $11,011 - $15,984	-35,521 Reduced 54.64%	29,485 $10,000
Q4 2021 Feb 14, 2022	BUY	$0.39 - $0.74 $20,639 - $39,161	52,921 Added 437.91%	65,006 $25,000
Q3 2021 Nov 15, 2021	SELL	$0.54 - $2.29 $9,259 - $39,268	-17,148 Reduced 58.66%	12,085 $7,000
Q2 2021 Aug 13, 2021	SELL	$0.97 - $2.39 $23,016 - $56,709	-23,728 Reduced 44.8%	29,233 $68,000
Q1 2021 May 12, 2021	BUY	$0.97 - $2.73 $51,372 - $144,583	52,961 New	52,961 $75,000
Q2 2020 Jul 31, 2020	SELL	$1.19 - $4.38 $14,865 - $54,714	-12,492 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$1.55 - $4.56 $16,347 - $48,094	10,547 Added 542.26%	12,492 $34,000
Q4 2019 Feb 14, 2020	SELL	$1.7 - $5.99 $1,324 - $4,666	-779 Reduced 28.6%	1,945 $9,000
Q3 2019 Nov 14, 2019	BUY	$5.77 - $7.65 $15,423 - $20,448	2,673 Added 5241.18%	2,724 $16,000
Q2 2019 Aug 14, 2019	BUY	$6.09 - $9.1 $310 - $464	51 New	51 $0
Q1 2019 May 14, 2019	SELL	$4.88 - $8.17 $644 - $1,078	-132 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.01 - $7.9 $661 - $1,042	132 New	132 $1,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $27.9M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.